As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Neostellar Capital Corp. The largest reported stake is Gamco Investors, Inc. Et Al's, at 6.1%. 3 filings are on record since July 16, 2025 (Schedule 13D/A, September 16, 2026).
Sell to companies like Neostellar Capital Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Gamco Investors, Inc. Et Al · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13D/A, 2026-09-16
- · Holder: Gamco Investors, Inc. Et Al · Percent: 5% · SCHEDULE 13D/A
- · Reporting person: Thomas J. Herzfeld Advisors, Inc. · Sole voting: 169,444 · Shared voting: 0 · Sole dispositive: 169,444 · Shared dispositive: 0 · SCHEDULE 13G/A, 2025-07-16
Neostellar Capital Corp. has 3 Schedule 13D or 13G filings on record since 2025-07-16. 1 holder's latest filing reports 5% or more of common stock, par value $.01 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Gamco Investors, Inc. Et Al | 6.1% | 0 | SCHEDULE 13D/A, 2026-09-16 | 2026-09-15 |
| Thomas J. Herzfeld Advisors, Inc. | 0.72% | 169,444 | SCHEDULE 13G/A, 2025-07-16 | 2025-06-03 |
Holding shares or following this stake? See who's behind Neostellar Capital Corp. and the warning signs.
Free to see. No signup.
Keep reading
More on Neostellar Capital Corp. and the records around it.
Neostellar Capital Corp. elsewhere on the record
- Leadership changes Jul 2026
- Who owns it
Companies that share a holder
- Thomas J. Herzfeld Advisors, Inc. also filed stake reports on 4 other companies: Saba Capital Income & Opportunities Fund II (Apr 2026), HIGHLAND OPPORTUNITIES & INCOME FUND (Oct 2025), Destra Multi-Alternative Fund (Jul 2025)
- GAMCO INVESTORS, INC. ET AL also filed stake reports on 45 other companies: NATHANS FAMOUS, INC. (Oct 2026), BEASLEY BROADCAST GROUP INC (Oct 2026), TENNANT CO (Sep 2026)
Watch Neostellar Capital Corp.
Get an email when Neostellar Capital Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Neostellar Capital Corp.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Neostellar Capital Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neostellar Capital Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Gamco Investors, Inc. Et Al | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-09-16 |
| Gabelli Funds LLC | 1,614,410 | 0 | 1,614,410 | 0 | SCHEDULE 13D/A, 2026-09-16 |
| GAMCO Asset Management Inc. | 274,000 | 0 | 274,000 | 0 | SCHEDULE 13D/A, 2026-09-16 |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 2,000 | 0 | 2,000 | 0 | SCHEDULE 13D/A, 2026-09-16 |
| Gabelli Foundation, Inc. | 5,000 | 0 | 5,000 | 0 | SCHEDULE 13D/A, 2026-09-16 |
| Ggcp, Inc. | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-09-16 |
| Associated Capital Group, Inc. | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-09-16 |
| Gabelli Mario J | 0 | 0 | 0 | 0 | SCHEDULE 13D/A, 2026-09-16 |
| Thomas J. Herzfeld Advisors, Inc. | 169,444 | 0 | 169,444 | 0 | SCHEDULE 13G/A, 2025-07-16 |
The latest filing identifies Neostellar Capital Corp. by CUSIP 86887Q109 and gives its principal executive office as 640 FIFTH AVENUE, NEW YORK, NY 10019 (SCHEDULE 13D/A, 2026-09-16).
Source of funds (Item 3)
The Reporting Persons used an aggregate of approximately $3,318,846 to purchase the additional Securities reported as beneficially owned in Item 5 since the most recent filing on Schedule 13D. GAMCO and Gabelli Funds used approximately $145,056 and $3,168,796, respectively, of funds that were provided through the accounts of certain of their investment advisory clients (and, in the case of some of such accounts at GAMCO, may be through borrowings from client margin accounts) in order to purchase the additional Securities for such clients.Gamco Investors, Inc. Et Al, SCHEDULE 13D/A, 2026-09-16
Purpose of Transaction (Item 4)
Gamco Investors, Inc. Et Al
The Reporting Persons file the long form Schedule 13D pursuant to Section 13d-1 of the Securities Exchange Act of 1934 (the "Act") even though they may be technically eligible to file the short form Schedule G. Because the Reporting Persons may regularly communicate with the Issuer's management, filing the Schedule 13D ensures that these conversations are compliant with the reporting obligations under the Exchange Act.Item 4 of the SCHEDULE 13D/A filed 2026-09-16
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-16 | Thomas J. Herzfeld Advisors, Inc. | 0.72% | SCHEDULE 13G/A |
| 2025-11-21 | Gamco Investors, Inc. Et Al | 5% | SCHEDULE 13D/A |
| 2026-09-16 | Gamco Investors, Inc. Et Al | 6.1% | SCHEDULE 13D/A |
Questions about who owns Neostellar Capital Corp.
Who owns Neostellar Capital Corp.?
On this page, one holder's latest ownership filing reports 5% or more of Neostellar Capital Corp.: Gamco Investors, Inc. Et Al (6.1%, Schedule 13D/A, filed 2026-09-16).
When did Gamco Investors, Inc. Et Al buy into Neostellar Capital Corp.?
The filings give report dates, not purchase dates. The earliest filing from Gamco Investors, Inc. Et Al on this page is the Schedule 13D/A, filed 2025-11-21, reporting 5%; its latest, Schedule 13D/A filed 2026-09-16, reports 6.1%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Neostellar Capital Corp.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 21, 2026 | Leadership change: Erik Falk appointed, Director | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Neostellar Capital Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.